342 related articles for article (PubMed ID: 31741756)
1. Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors.
Yang S; Wu Y; Deng Y; Zhou L; Yang P; Zheng Y; Zhang D; Zhai Z; Li N; Hao Q; Song D; Kang H; Dai Z
Oncoimmunology; 2019; 8(12):e1659094. PubMed ID: 31741756
[TBL] [Abstract][Full Text] [Related]
2. Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma.
Xu Y; Wang Z; Li F
Transl Oncol; 2021 Jan; 14(1):100957. PubMed ID: 33246289
[TBL] [Abstract][Full Text] [Related]
3. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
Wu P; Sun W; Zhang H
Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303
[TBL] [Abstract][Full Text] [Related]
4. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
5. Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors.
Ding Z; Li R; Han J; Sun D; Shen L; Wu G
Front Cell Dev Biol; 2021; 9():739583. PubMed ID: 34722522
[TBL] [Abstract][Full Text] [Related]
6. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
7. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
Front Immunol; 2020; 11():1933. PubMed ID: 33072067
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer.
Qian Y; Wei J; Lu W; Sun F; Hwang M; Jiang K; Fu D; Zhou X; Kong X; Zhu Y; Xiao Q; Hu Y; Ding K
Front Genet; 2021; 12():619611. PubMed ID: 33747044
[TBL] [Abstract][Full Text] [Related]
9. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
Liu J; Chen X; Jiang Y; Cheng W
Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.
Du H; Pang S; Li Y; Zhu L; Hang J; Chen L
J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327
[TBL] [Abstract][Full Text] [Related]
11. Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration.
Liu J; Meng H; Nie S; Sun Y; Jiang P; Li S; Yang J; Sun R; Cheng W
Genomics; 2020 Nov; 112(6):4827-4841. PubMed ID: 32890701
[TBL] [Abstract][Full Text] [Related]
12. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer.
Pi YN; Guo JN; Lou G; Cui BB
Cancer Cell Int; 2021 Dec; 21(1):639. PubMed ID: 34852825
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer.
Zhang ZC; Guo JN; Zhang N; Wang ZQ; Lou G; Cui BB; Yang C
Front Immunol; 2021; 12():763791. PubMed ID: 34880862
[TBL] [Abstract][Full Text] [Related]
15. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
[TBL] [Abstract][Full Text] [Related]
16. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
17. Prediction of overall survival and response to immune checkpoint inhibitors: An immune-related signature for gastric cancer.
Wang Z; Li X; Xu Y
Transl Oncol; 2021 Jun; 14(6):101082. PubMed ID: 33784584
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma.
Liu N; Liu Z; Liu X; Duan X; Huang Y; Jin Z; Niu Y; Zhang L; Chen H
Front Genet; 2020; 11():1002. PubMed ID: 33005180
[TBL] [Abstract][Full Text] [Related]
19. A 25 Immune-Related Gene Pair Signature Predicts Overall Survival in Cervical Cancer.
Chen H; Xie H; Wang P; Yan S; Zhang Y; Wang G
Cancer Inform; 2022; 21():11769351221090921. PubMed ID: 35464777
[TBL] [Abstract][Full Text] [Related]
20. The role of an immune signature for prognosis and immunotherapy response in endometrial cancer.
Meng Y; Yang Y; Zhang Y; Yang X; Li X; Hu C
Am J Transl Res; 2021; 13(2):532-548. PubMed ID: 33594308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
